Diminished NF-κB activation and PDGF-B expression in glomerular endothelial cells subjected to chronic shear stress

Microvascular Research

Volumn 65, Issue 3, 2003, Pages 137-144

  Eng, Eudora ^a,b   Ballermann, Barbara J ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Differentiation; Glomerular endothelial cell; NF B; PDGF B; Transcriptional regulation

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR B;

ANIMAL CELL; ARTERY ENDOTHELIUM; ARTICLE; CATTLE; CELL LEVEL; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GLOMERULUS; GLOMERULUS CAPILLARY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SHEAR STRESS; TRANSCRIPTION REGULATION;

BOVINAE;

EID: 0037404743     PISSN: 00262862     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-2862(03)00004-9     Document Type: Article

References (31)

1. Andrews N.C., Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 10:1991;2499.
2. Ballermann B.J. Regulation of bovine glomerular endothelial cell growth in vitro. Am. J. Physiol. 256:1989;C182-C189.
3. Baeuerle P.A., Baltimore D. IkB a specific inhibitor of the NF-κB transcription factor. Science. 242:1988;540-546.
4. Beg A.A., Sha W.C., Bronson R.T., et al. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature. 376:1995;167-170.
5. Folkman J., Haudenschild C.C., Zetter B.R. Long-term culture of capillary endothelial cells. Proc. Natl. Acad. Sci. 76:1979;5217-5221.
6. Foo S.Y., Nolan G.P. NF-κB to the rescue RELs, apoptosis and cellular transformation. Trends Genet. 15:1999;229-235.
7. Grimm S., Bauer M.K., Baeuerle P.A., et al. Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis. J. Cell Biol. 134:1996;13-23.
8. Hellstrom M., Kal M., Lindahl P., et al. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development. 126:1999;3047-3055.
9. Hinz M., Krappmann D., Eichten A., et al. NF-kappaB function in growth control regulation of cyclin D1 expression and G0-G1-to-S-phase transition. Mol. Cell. Biol. 19:1999;2690-2698.
10. Hsieh H.J., Li N.Q., Frangos J.A. Shear stress increases endothelial platelet-derived growth factor mRNA levels. Am. J. Physiol. 260:1991;H642-H646.
11. Hsu S.C., Gavrilin M.A., Lee H.H., et al. NF-kappa B-dependent Fas ligand expression. Eur. J. Immunol. 29:1999;2948-2956.
12. Khachigian L.M., Lindner V., Williams A.J., et al. Egr-1-induced endothelial gene expression a common theme in vascular injury. Science. 271:1996;1427-1431.
13. Khachigian L.M., Reznick N., Gimbrone M.A., et al. Nuclear factor-kappa B interacts functionally with the platelet-derived growth factor B-chain shear-stress response element in vascular endothelial cells exposed to fluid shear stress. J. Clin. Invest. 96:1995;1169-1175.
14. Kumar S., West D.C., Ager A. Heterogeneity in endothelial cells from large vessels and microvessels. Differentiation. 36:1997;57-70.
15. Leveen P., Pekny M., Gebre-Medhin S., et al. Mice deficient for PDGF B show renal, cardiovascular, and hematologic abnormalities. Genes Dev. 8:1994;1875-1887.
16. Lindahl P., Hellstrom M., Kalen M., et al. Paracrine PDGF-B/PDGF-R beta signaling controls mesangial cell development in kidney glomeruli. Development. 125:1998;3313-3322.
17. Malek A.M., Gibbons G.H., Dzau V.J., et al. Fluid shear stress differentially modulates expression of genes encoding basic fibroblast growth factor and platelet-derived growth factor B chain in vascular endothelium. J. Clin. Invest. 92:1993;2013-2021.
18. Matsuda M., Shikata K., Makino H., et al. Gene expression of PDGF and PDGF receptor in various forms of glomerulonephritis. Am. J. Nephrol. 17:1997;25-31.
19. Mondy J.S., Lindner V., Miyashiro J.K., et al. Platelet-derived growth factor ligand and receptor expression in response to altered blood flow in vivo. Circ. Res. 81:1997;320-327.
20. Nagel T., Resnick N., Dewey C.F., et al. Vascular endothelial cells respond to spatial gradients in fluid shear stress by enhanced activation of transcription factors. Arterioscler. Thromb. Vasc. Biol. 19:1999;1825-1834.
21. Naito T., Nitta K., Ozu H., et al. Clinical assessment of the significance of platelet-derived growth factor in patients with immunoglobulin A nephropathy. J. Lab. Clin. Med. 130:1997;63-68.
22. Ott M.J., Olson J.L., Ballermann B.J. Chronic in vitro flow promotes ultrastructural differentiation of endothelial cells. Endothelium. 3:1995;21-30.
23. Page C., Rose M., Yacoub M., et al. Antigenic heterogeneity of vascular endothelium. Am. J. Pathol. 141:1992;673-683.
24. Perkins N.D. Achieving transcriptional specificity with NF-kappa B. Int. J. Biochem. Cell Biol. 29:1997;1433-1448.
25. Resnick N., Collins T., Atkinson W., et al. Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress-responsive element. Proc. Natl. Acad. Sci. USA. 90:1993;4591-4595.
26. Seifert R.A., Alpers C.E., Bowen-Pope D.F. Expression of platelet-derived growth factor and its receptors in the developing and adult mouse kidney. Kidney Int. 54:1998;731-746.
27. Silverman M.D., Waters C.R., Hayman G.T., et al. Tissue factor activity is increased in human endothelial cells cultured under elevated static pressure. Am. J. Physiol. 277:1999;C233-C242.
28. Stein-Oakley A.N., Maguire J.A., Dowling J., et al. Altered expression of fibrogenic growth factors in IgA nephropathy and focal and segmental glomerulosclerosis. Kidney Int. 51:1997;195-204.
29. Terada Y., Yamada T., Nakashima O., et al. Expression of PDGF and PDGF receptor mRNA in glomeruli in IgA nephropathy. J. Am. Soc. Nephrol. 8:1997;817-819.
30. Wang C.Y., Mayo M.W., Baldwin A.S. Jr. TNF- and cancer therapy-induced apoptosis potentiation by inhibition of NF-kappa B. Science. 247:1996;784-787.
31. Wang C.Y., Mayo M.W., Korneluk R.G., et al. NF-kappa B antiapoptosis induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science. 281:1998;1680-1683.